Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
15.96
-0.10 (-0.62%)
Jul 21, 2026, 3:00 PM CST

SHA:600535 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-1,4362,9944,4513,1192,304
Short-Term Investments
-1,404----
Trading Asset Securities
-1,394524.72300.711,1251,487
Cash & Short-Term Investments
4,3544,2343,5184,7514,2443,791
Cash Growth
2.99%20.34%-25.95%11.95%11.95%78.94%
Accounts Receivable
-2,4181,9662,1313,3483,796
Other Receivables
-39.9623.0611.498.989.47
Receivables
-2,4581,9892,1423,3573,805
Inventory
-1,4271,7121,7481,5321,548
Other Current Assets
-111.591.7291.43127.08105
Total Current Assets
-8,2307,3118,7339,2609,249
Property, Plant & Equipment
-3,5463,6483,7693,8834,088
Long-Term Investments
-1,3461,8212,0541,5111,229
Goodwill
---15.8815.88167.08
Other Intangible Assets
-794.39604.17573.64459.43474.54
Long-Term Deferred Tax Assets
-67.0553.175088.2960.79
Long-Term Deferred Charges
-1,3331,4661,4761,1571,193
Other Long-Term Assets
-22.6672.5443.14102.0879.68
Total Assets
-15,34014,97616,71416,47716,542
Accounts Payable
-376.9606.81572.73887.77728.58
Accrued Expenses
-537.57171.05178.38242.79213.15
Short-Term Debt
-1,116699.54814.63201.77188.79
Current Portion of Long-Term Debt
-4.96586.83462.74475.21343.33
Current Portion of Leases
-49.747.8458.5453.9855.67
Current Income Taxes Payable
-110.9157.7818.0484.62108.09
Current Unearned Revenue
-49.8869.8591.6292.3568.33
Other Current Liabilities
-62.39109.98172.88108.72149.12
Total Current Liabilities
-2,3082,3502,3702,1471,855
Long-Term Debt
-216.87253.761,4141,3761,034
Long-Term Leases
-51.1967.9781.5275.3181.63
Long-Term Unearned Revenue
-189.95193.29159.02177.79214.57
Long-Term Deferred Tax Liabilities
-26.020.40.1122.8742.18
Total Liabilities
-2,7922,8654,0243,7993,228
Common Stock
-1,4941,4941,5001,5001,513
Additional Paid-In Capital
-482.39458.96958.081,4571,530
Retained Earnings
-10,3919,8989,9299,35110,222
Treasury Stock
----105.98-105.98-251.29
Comprehensive Income & Other
-37.2452.2288211.58-32.19
Total Common Equity
12,76812,40411,90312,36812,41212,981
Minority Interest
-143.49207.86321.59265.12332.56
Shareholders' Equity
12,90612,54812,11112,69012,67813,314
Total Liabilities & Equity
-15,34014,97616,71416,47716,542
Total Debt
1,1491,4381,6562,8312,1821,704
Net Cash (Debt)
3,2052,7951,8621,9202,0622,088
Net Cash Growth
26.50%50.10%-2.99%-6.89%-1.23%-
Net Cash Per Share
2.151.871.251.291.401.39
Filing Date Shares Outstanding
1,4941,4941,4941,4941,4941,499
Total Common Shares Outstanding
1,4941,4941,4941,4941,4941,499
Working Capital
-5,9224,9616,3637,1137,394
Book Value Per Share
8.558.307.978.288.318.66
Tangible Book Value
11,99111,61011,29911,77911,93712,340
Tangible Book Value Per Share
8.037.777.567.887.998.23
Buildings
-3,5293,5173,5053,4903,398
Machinery
-3,8033,7633,6253,4723,340
Construction In Progress
-322.42221.76153.87102.96167.85